Skip to main content scroll back to top of page

Chimerix is now part of Jazz Pharmaceuticals. Learn more at www.jazzpharma.com

Chimerix Logo

Utility Navigation

Chimerix Logo

Primary Navigation

Close Menu
  • Patients
    • Expanded Access
    • Clinical Trials
  • About Imipridones
    • About Impipridones
      About ImpipridonesImipridones

      Oncology: Imipridones

      • ONC201 dordaviprone for gliomas
      • ONC206 for central nervous system tumors
      • ONC212 IND-enabling studies
      PublicationsNeuro Oncology Publications2024 SNO Annual Conference
  • Careers
  • Contact

Privacy Notice

Last Modified: October 31, 2023

CHIMERIX PRIVACY NOTICE


Chimerix Logo
  • Chimerix on LinkedIn
  • Chimerix on Twitter

Legal Menu

  • Privacy Notice
  • Cookie Notice 
  • Terms & Conditions of Use
  • Forward-Looking Statements
  • Community Guidelines

© 2025 Copyright Chimerix. All rights reserved.

Chimerix is now part of Jazz Pharmaceuticals

Select Jazz for more information about Jazz Pharmaceuticals.
Select continue to proceed to the Chimerix website.

Jazz